Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

Process Update

20 Sep 2024 07:02

RNS Number : 0242F
Thames Water Utilities Limited
20 September 2024
Β 

Thames Water Utilities Limited

20 September 2024

Process Update

Β 

We previously announced that following the Price Review 2024 ("PR24") draft determination and our response to Ofwat, we would be engaging with potential investors and creditors to seek new equity and to extend our liquidity runway.

Β 

We submitted our response to Ofwat's draft determination for 2025 to 2030 on 28 August 2024. We plan to launch our formal equity solicitation process in the coming weeks. Any equity process is not expected to conclude until after the Final Determination, originally due in December 2024, which Ofwat are consulting on moving to January 2025. We will have the option to request an appeal of the Final Determination to the CMA.

Β 

We have been engaging with financial stakeholder groups and their advisors since July 2024 and are assisting with information requests to enable financial stakeholder groups to better understand Thames Water's business plan and future funding needs.

Β 

As at 31 August 2024, we had Β£1.57 billion of liquidity consisting of Β£1.15 billion of cash and cash equivalents (Β£0.38 billion of which is currently required to be placed in reserves under our financing) and Β£0.42 billion of Class A and Class B undrawn committed facilities. A further Β£0.55 billion of undrawn reserve liquidity facilities are available to support Thames Water should we enter standstill under our financing. The combination of these resources provides a liquidity runway to May 2025.

Β 

As contingency planning, we have entered into discussions with our financial stakeholders to release cash reserves under our financing. This would require majority creditor consent. If consent were not forthcoming and should it not be possible to draw the Class A and/or Class B facilities, available cash and cash equivalents would expire at the end of December 2024, whereupon we would enter standstill under our financing and the Β£0.55 billion undrawn reserve liquidity facilities and Β£0.38 billion of cash reserves would become available.

Β 

We, together with our financial stakeholders, are considering options for the extension of our liquidity runway to enable time to complete a recapitalisation transaction. In parallel, we continue to undertake contingency planning as a matter of good corporate practice.

Β 

For further information

Investor enquiries

Frederick Maroudas - Director of Corporate Finance debt.investorrelations@thameswater.co.uk

Media enquiries

Simon Haynes - Media Relations Manager07747644910simon.haynes@thameswater.co.uk

Matt Young - Apella Advisors07802 332292 my@apellaadvisors.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDFIFEEAAIIFIS
12
Date   Source Headline
5th Jun 202610:01 amRNSEleventh Consent Requests - Super Senior Funding
3rd Jun 20269:07 amRNSResults of Tenth Consent Request
18th May 202610:05 amRNSTenth Consent Request - Super Senior Funding
24th Apr 20269:00 amRNSResults of Ninth Consent Requests
9th Apr 202610:00 amRNSNinth Consent Requests - Super Senior Funding
17th Mar 20261:29 pmRNSResults of Eighth Consent Requests & STID Proposal
16th Mar 20267:00 amRNSRecapitalisation Update on L&VW’s Proposal
2nd Mar 20262:22 pmRNSEighth Consent Requests and STID Proposal
12th Feb 20269:00 amRNSLiquidity Extension Update
8th Jan 202610:22 amRNSResults of Seventh Consent Requests
19th Dec 202511:41 amRNSSeventh Consent Requests - Super Senior Funding
19th Dec 202510:30 amRNSResults of STID Proposals & Sixth Consent Requests
4th Dec 20252:53 pmRNSSTID Proposals and Sixth Consent Requests
3rd Dec 20257:14 amRNSInterim Financial Statements
3rd Dec 20257:00 amRNSInterim Financial Statements
24th Nov 20259:00 amRNSFifth Consent Requests (Results)
10th Nov 20259:00 amRNSFifth Consent Requests - Super Senior Funding
21st Oct 202510:00 amRNSCMA Reference Deferral Update
9th Oct 20252:45 pmRNSRecapitalisation Update - Class B Ad Hoc Group
22nd Sep 202510:06 amRNSTWUL - Fourth Consent Requests (Results)
5th Sep 202511:00 amRNSFourth Consent Requests - Super Senior Funding
27th Aug 20257:00 amRNSInvestigations Update - Payment Plan
15th Aug 20257:00 amRNSLiquidity Extension Update
23rd Jul 20257:00 amRNSAnnual Financial Report
22nd Jul 20257:00 amRNSAnnual Financial Report
18th Jul 20252:44 pmRNSCMA Reference Deferral Update
15th Jul 20257:01 amRNSAnnual Financial Report
15th Jul 20257:00 amRNSResults of the Third Consent Requests
30th Jun 202511:03 amRNSThird Consent Requests Super Senior Issuer Funding
3rd Jun 20257:00 amRNSEquity Raise Update
28th May 20257:10 amRNSInvestigations Update
14th May 20251:07 pmRNSResults of the Second Consent Requests
28th Apr 20252:05 pmRNSSecond Super Senior Funding Waiver Consent Request
2nd Apr 202512:00 pmRNSThames Water appoints new Chief Financial Officer
1st Apr 20255:13 pmRNSResults of STID Proposal and Consent Requests
31st Mar 20257:00 amRNSEquity Raise Update
28th Mar 202512:00 pmRNSThames Water Chief Financial Officer Steps Down
18th Mar 202512:25 pmRNSCMA and Equity Raise Update
17th Mar 20253:10 pmRNSTWUL - Update on Super Senior Funding Waiver
17th Mar 202511:16 amRNSRestructuring Plan Upheld
21st Feb 20254:18 pmRNSNotice of Plan Effective Date
18th Feb 20259:30 amRNSRestructuring Plan Sanctioned
14th Feb 20257:00 amRNSTWUL - Referral of Final Determination to CMA
11th Feb 20252:35 pmRNSEquity Raise Process Update
10th Feb 202511:37 amRNSTWUL - STID Proposal Results
31st Jan 20253:56 pmRNSLiquidity Extension Update - Sanction Hearing
24th Jan 20253:43 pmRNSLiquidity Extension Update
22nd Jan 20254:24 pmRNSLiquidity Extension Update
10th Jan 20254:37 pmRNSTWUL - STID Proposal Results
7th Jan 20254:24 pmRNSLiquidity Extension Update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.